8-K: PMI Exceeds 2025 Targets, Boosts Smoke-Free Growth

Philip Morris International reports strong 2025 full-year results, driven by significant growth in its smoke-free business, and provides optimistic 2026-2028 growth targets.

Summary

• Full-Year 2025 Reported Diluted EPS was $7.26, a significant increase from $4.52 in 2024.
• Full-Year 2025 Adjusted Diluted EPS reached $7.54, representing growth of 14.8%, and 14.2% on a currency-neutral basis.
• Net revenues for the full year surpassed $40 billion, with close to $17 billion generated from the smoke-free business.
• The smoke-free business (SFB) delivered strong performance, with full-year shipment volumes up by 12.8%, net revenues growing by 15.0% (14.1% organically), and gross profit increasing by 20.3% (18.7% organically).
• SFB accounted for 41.5% of total net revenues and nearly 43% of total gross profit in 2025.
• Smoke-free products are now available in 106 markets, with over 43 million estimated adult consumers, an increase of approximately 4.5 million versus December 2024.
• IQOS continued to drive growth in the global heat-not-burn category, where PMI holds approximately 76% volume share.
• Oral smoke-free product shipment volume increased by 18.5% for the full year, fueled by nicotine pouches which grew nearly 37% in the U.S. and over 35% internationally.
• VEEV e-vapor shipment volumes more than doubled on a full-year basis, notably driven by Europe and Indonesia.
• Combustibles net revenues grew by 2.5% (1.8% organically) for the full year, driven by strong pricing despite expected lower volumes.
• A regular quarterly dividend of $1.47 per share was declared, equating to an annualized $5.88 per share.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong positive report, highlighting excellent financial performance, significant progress in the smoke-free transition, and robust future growth targets, despite ongoing challenges in the combustibles segment.

Positives

• Achieved a fifth consecutive year of volume growth, demonstrating sustained market presence and consumer demand.
• Net revenues surpassed $40 billion, indicating strong top-line performance and market penetration.
• Delivered three-year CAGR targets on operating income and EPS in just two years, showcasing efficient execution and accelerated growth.
• Smoke-free business (SFB) exhibited robust growth, with shipment volumes up 12.8%, net revenues up 15.0% (14.1% organically), and gross profit up 20.3% (18.7% organically).
• SFB now represents a significant portion of the business, accounting for 41.5% of total net revenues and nearly 43% of total gross profit.
• The number of estimated adult consumers of smoke-free products grew by approximately 4.5 million to over 43 million by December 2024.
• IQOS maintains a dominant position in the global heat-not-burn category with approximately 76% volume share and is the #1 volume share position in 13 markets.
• ZYN nicotine pouches showed exceptional growth, increasing by nearly 37% in the U.S. and over 35% in international markets.
• VEEV e-vapor shipment volumes more than doubled year-on-year, indicating strong adoption and expansion in the e-vapor segment.
• Combustibles business maintained revenue growth of 2.5% (1.8% organically) through strong pricing, partly offsetting volume declines.
• Marlboro achieved a record high 11.0% category share in the fourth quarter.
• The company is targeting further net debt to adjusted EBITDA ratio improvement to close to 2.0x by the end of 2026.

Negatives

• Total cigarette shipment volume declined by 1.5% for the full year and 2.2% in the fourth quarter.
• Overall cigarette category share was slightly lower for the full-year, predominantly due to performance in Turkey.
• Oral SFP shipments in Europe decreased, primarily driven by lower snus volume due to inventory movements and a strong prior-year comparator for nicotine pouches in the Nordics.
• The Americas region experienced a 4.4% organic net revenue decrease and a 43.4% organic adjusted operating income decrease in the fourth quarter, mainly due to an unfavorable price comparison for ZYN and higher marketing, administration, and research costs.
• The 2026 full-year forecast assumes an estimated total international industry volume decline of around 2% for cigarettes and HTUs, excluding China and the U.S.

Risks

• Marketing and regulatory restrictions that could reduce competitiveness, disrupt SFP commercialization efforts, eliminate the ability to communicate with adult consumers, or ban certain products in specific markets or countries.
• Excise tax increases and discriminatory tax structures.
• Health concerns relating to the use of tobacco and other nicotine-containing products.
• Litigation related to tobacco and/or nicotine products and intellectual property rights.
• Intense competition from other market participants.
• Inability to anticipate changes in adult consumer preferences.
• Reliance on third-parties for various business operations.
• Adverse effects of global and individual country economic, regulatory, and political developments, natural disasters, and conflicts.
• Geopolitical instability affecting international trade, such as the impact and consequences of Russia's invasion of Ukraine.
• Changes in adult smoker behavior and continued decline of tax-paid cigarettes.
• Lost revenues as a result of counterfeiting, contraband, and cross-border purchases.
• Governmental investigations.
• Unfavorable currency exchange rates and currency devaluations, sustained periods of elevated inflation, and limitations on the ability to repatriate funds.
• Adverse changes in applicable corporate tax laws.
• Disruptions in the credit markets or changes to credit ratings.
• Recent and potential future tariffs imposed by the U.S. and other countries.
• Adverse changes in the cost, availability, and quality of tobacco and other agricultural products and raw materials, as well as product components for electronic devices.
• The integrity of information systems and effectiveness of data privacy policies.
• Unsuccessful efforts, in key markets or systemically, to introduce, commercialize, and grow smoke-free products, or if regulation or taxation does not differentiate between such products and cigarettes.
• Inability to successfully introduce new products, promote brand equity, or if there are prolonged disruptions of facilities used to produce products.
• Inability to enter new markets or improve margins through increased prices and productivity gains.
• Inability to attract and retain the best global talent.
• Inability to successfully integrate and realize the expected benefits from recent transactions and acquisitions.
• Lower predictability of smoke-free products performance.

Future Outlook

The company forecasts 2026 reported diluted EPS to be in a range of $7.87 to $8.02. Excluding currency impact, adjusted diluted EPS is projected to increase by 7.5% to 9.5% from $7.54 in 2025. This forecast assumes an estimated total international industry volume decline of around 2% for cigarettes and heated tobacco units (excluding China and the U.S.), broadly stable total PMI cigarette and smoke-free product shipment volume with high-single digit smoke-free product growth, and a cigarette shipment volume decline of around 3%. Organic net revenue growth is projected at 5% to 7%, and organic operating income growth at 7% to 9% for 2026. For the 2026-2028 period, new compound annual growth targets include 6% to 8% for organic net revenues, 8% to 10% for organic operating income, and 9% to 11% for adjusted diluted EPS (excluding currency, assuming current corporate income tax rates and no share repurchases).

Management Comments

• "We achieved another remarkable year of results in 2025, with a fifth consecutive year of volume growth, net revenues surpassing $40 billion, including close to $17 billion from our smoke-free business, and very good operating margin expansion." Jacek Olczak, Group CEO PMI.
• "With excellent results in 2024 and 2025, we have delivered our three-year CAGR targets on operating income and EPS in just two years. With another strong performance expected in 2026, we are on track to outperform our 2024-2026 growth algorithm. This again demonstrates our ability to create sustainable value for our shareholders as we renew our growth targets for 2026-2028." Jacek Olczak, Group CEO PMI.
• PMI remains committed to building and commercializing the VEEV brand in a focused, responsible and profitable manner.

Industry Context

StockSavvy.ai notes that PMI's strong performance, particularly in its smoke-free portfolio, aligns with the broader global trend of declining traditional cigarette consumption and increasing adoption of reduced-risk nicotine products. The company's strategic shift towards a 'smoke-free future' positions it well within an evolving industry landscape, where regulatory pressures and consumer health awareness are driving innovation away from combustibles. The growth of IQOS, ZYN, and VEEV demonstrates successful adaptation to these trends, contrasting with the general decline in the traditional tobacco market. The new organizational structure further emphasizes this strategic pivot.

Comparison to Industry Standards

• IQOS holds approximately 76% volume share of the global heat-not-burn category, significantly outperforming competitors in this segment.
• IQOS is the second-largest nicotine brand in markets where present and holds the #1 volume share position in 13 markets, indicating strong market penetration and consumer preference compared to other nicotine product brands.
• ZYN leads the U.S. nicotine pouch category with around two-thirds value share in 2025, demonstrating a dominant position against other oral nicotine product brands.
• VEEV holds the #1 volume share position in 8 markets within the closed pods e-vapor segment, indicating strong competitive performance in specific e-vapor markets.

Corporate Governance

Stakeholder Impact

• Shareholders: Positive impact due to strong financial performance, a declared dividend of $1.47 per share, and optimistic future growth targets, potentially leading to increased share value and consistent returns.
• Employees: Impacted by the evolved organizational model and new segment reporting, which may lead to restructuring or reallocation of roles within the new International and U.S. business units.
• Customers: Continued focus on expanding smoke-free product availability (now in 106 markets) and innovation (e.g., 1.5mg ZYN variants) offers more choices for legal-age nicotine consumers.
• Regulatory Authorities: The company's commitment to a 'smoke-free future' and FDA authorizations for certain SFPs (General snus, ZYN, IQOS) indicate ongoing engagement and compliance with regulatory bodies, though regulatory restrictions remain a key risk.

Next Steps

• Outperform the 2024-2026 growth algorithm.
• Implement an evolved organizational model with two primary business units: International and U.S., effective January 1, 2026.
• Realign reportable segments to International Smoke-Free, International Combustibles, and U.S. as of the first quarter of 2026.
• Disclose select historical financial information for the 2023 to 2025 period based on the new reportable segments before the end of the first quarter of 2026.
• Host a conference call on February 6, 2026, at 9:00 a.m., Eastern Time, to discuss results and outlook.

Key Dates

Recommendation

The filing demonstrates exceptional financial performance in 2025, significantly exceeding previous growth targets and setting ambitious new ones for 2026-2028. The robust growth of the smoke-free business, which now constitutes a substantial portion of revenues and profits, indicates a successful strategic transformation away from traditional combustibles. Strong dividend payouts, coupled with a clear path for future expansion and profitability, make PMI an attractive investment for long-term growth and income-focused investors. The company's dominant market share in key smoke-free categories further solidifies its competitive advantage.

Keywords

Philip Morris International, PMI, PM, SEC filing, earnings, financial results, smoke-free products, IQOS, ZYN, VEEV, heated tobacco, nicotine pouches, e-vapor, combustibles, tobacco, consumer goods, corporate governance, risk management, financial analysis, dividend, EPS, revenue, operating income, 8-K